CUE vs XEL · rev $13.6M vs P/E 20, $39.33B cap
Cue Biopharma (CUE) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported CUE revenue for 2026-06-30 was $13.6M. Net income was -$158.2M. CUE currently screens at market cap $59.5M.
XEL does not have a complete income-statement cache yet.
CUE currently screens at market cap $59.5M. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the CUE and XEL stock pages for the full models.
Not investment advice.